Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)
Close on Nov 17, 2026Market cap $1.89BP/E –Yield –
Fortrea cash
Cash and short-term investments held at the end of each period.
Fortrea's cash was $220.60M at Sep 30, 2026. For fiscal 2025 it was $174.60M, up 47.3% from the year before. The highest annual figure on record is $174.60M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $174.60M | +47.3% |
| FY2024 | Dec 31, 2024 | $118.50M | +9.1% |
| FY2023 | Dec 31, 2023 | $108.60M | -1.6% |
| FY2022 | Dec 31, 2022 | $110.40M | +16.7% |
| FY2021 | Dec 31, 2021 | $94.60M | +17.8% |
| FY2020 | Dec 31, 2020 | $80.30M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $220.60M | +68.0% |
| Q2 FY2026 | Jun 30, 2026 | $168.60M | +107.6% |
| Q1 FY2026 | Mar 31, 2026 | $147.50M | +45.2% |
| Q4 FY2025 | Dec 31, 2025 | $174.60M | +47.3% |
| Q3 FY2025 | Sep 30, 2025 | $131.30M | +24.7% |
| Q2 FY2025 | Jun 30, 2025 | $81.20M | -35.7% |
| Q1 FY2025 | Mar 31, 2025 | $101.60M | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $118.50M | +9.1% |
| Q3 FY2024 | Sep 30, 2024 | $105.30M | +1.4% |
| Q2 FY2024 | Jun 30, 2024 | $126.20M | +15.9% |
| Q1 FY2024 | Mar 31, 2024 | $92.80M | -21.5% |
| Q4 FY2023 | Dec 31, 2023 | $108.60M | -1.6% |
| Q3 FY2023 | Sep 30, 2023 | $103.80M | -3.4% |
| Q2 FY2023 | Jun 30, 2023 | $108.90M | +14.0% |
| Q1 FY2023 | Mar 31, 2023 | $118.20M | +24.9% |
| Q4 FY2022 | Dec 31, 2022 | $110.40M | +37.5% |
| Q3 FY2022 | Sep 30, 2022 | $107.50M | – |
| Q2 FY2022 | Jun 30, 2022 | $95.50M | – |
| Q4 FY2021 | Dec 31, 2021 | $94.60M | – |
| Q4 FY2020 | Dec 31, 2020 | $80.30M | – |
See a number that looks wrong?